A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500 mg in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Lobeglitazone/metformin (Primary) ; Lobeglitazone; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 08 Aug 2017 Status changed from active, no longer recruiting to completed.
- 21 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 23 Feb 2016 New trial record